Ly6G+ granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis.

Saved in:
Bibliographic Details
Title: Ly6G+ granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis.
Authors: Sharma P; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Sharma RD; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Sarkar B; National Institute of Immunology, New Delhi, India., Panwar V; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Das M; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Singh LV; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Jain N; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Chaturvedi S; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Mehra L; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India., Rathee A; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Sharma S; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Foo S; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Lee A; Infectious Diseases Labs (ID labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., N PK; Department of Immunology, ICMR-National Institute for Research in Tuberculosis, Chennai, India., Das P; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India., Viswanathan V; Prof. M. Viswanathan Diabetes Research Center, Chennai, India., Kornfeld H; Department of Medicine, University of Massachusetts Medical School, Worcester, United States., Howland SW; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore., Babu S; NIH-International Center of Excellence in Research, Chennai, India.; Laboratory of Parasitic Diseases, NIAID-NIH, Bethesda, United States., Nandicoori VK; National Institute of Immunology, New Delhi, India.; Centre for Cellular and Molecular Biology, Hyderabad, India., Singhal A; Infectious Diseases Labs (ID labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore, Singapore., Kumar D; Cellular Immunology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Source: ELife [Elife] 2026 Feb 05; Vol. 13. Date of Electronic Publication: 2026 Feb 05.
Publication Type: Journal Article
Journal Info: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2050-084X
DOI:10.7554/eLife.100966